HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics
More filters
2276studies shown
Showing 1,009-1,020 of 2,276
Drug study icon
CompletedNCT01192867

RO4917838 in people with Persistent, Predominant Negative Symptoms of Schizophrenia (NN25310)

Official study title

A Phase III, Multi-Center, Randomized, 24 Week, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate Efficacy and Safety of RO4917838 in Stable Patients With Persistent, Predominant Negative Symptoms of Schizophrenia Treated With Antipsychotics Followed by a 28 Week, Double-Blind Treatment Period

This study has finished and is no longer accepting participants.

In Australia
SchizophreniaMedication studyAges 18+
Countries
Australia, United States, France, + 11 others
Sponsor
Hoffmann-La Roche
Drug study icon
CompletedNCT00420823

Taurine for Schizophrenia

Official study title

A 12-week, Parallel, Double-blind, Randomised, Placebo-controlled Adjunctive Study of Taurine 4 Grams in 128 Patients With First-episode Psychosis Receiving Antipsychotic Treatment.

This study has finished and is no longer accepting participants.

In Australia
SchizophreniaMedication studyAges 18–25
Countries
Australia
Sponsor
Melbourne Health
Other study type icon
CompletedACTRN12614000429651

The Physical Health and Genetics of PTSD (PTSD).

Official study title

A Cross-Sectional, Case-Control Study of the Physical Health Status of Vietnam Veterans with and without Post-Traumatic Stress Disorder (PTSD) and Investigation of Genetics of PTSD.

This study has finished and is no longer accepting participants.

In Australia
PTSDObservational study
Countries
Australia
Sponsor
Returned Services League (RSL) Queensland
Device study icon
CompletedNCT00763230

Transcranial Direct Current Stimulation (tDCS) to Treat Depression

Official study title

A Sham-controlled Study of Transcranial Direct Current Stimulation (tDCS) as a Treatment for Depression

This study has finished and is no longer accepting participants.

In Australia
Depression, BipolarityDevice studyAges 18–75
Countries
Australia
Sponsor
The University of New South Wales
Drug study icon
CompletedACTRN12617000002381

Two different formulations of buprenorphine in healthy volunteers.

Official study title

An open label, two-­way crossover study to evaluate the absolute bioavailability of BnoX Trademark, a novel sublingual wafer formulation of buprenorphine, in healthy volunteers under fasted conditions.

This study has finished and is no longer accepting participants.

In Australia
AddictionInterventional studyAges 18–65
Countries
Australia
Sponsor
iX Biopharma Pty Ltd
Behavioral study icon
CompletedACTRN12617000060347

A study that test the effects of a mobile phone application that delivers a psychological health intervention to reduce social anxiety symptoms.

Official study title

Randomised Controlled Trail testing the effectiveness of an Ecological Momentary Intervention (EMI) in adults with social anxiety symptoms

This study has finished and is no longer accepting participants.

Remote / online
Anxiety, DepressionInterventional studyAges 18+
Countries
Australia
Sponsor
Australian National University
Drug study icon
CompletedNCT04292197

18-Methoxycoronaridine (18-MC HCl) in Healthy Volunteers

Official study title

A Phase 1, Double-Blind, Randomized, Placebo-Controlled, Single/Multiple Day Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of 18- Methoxycoronaridine (18-MC HCl) Administered Orally to Normal Healthy Volunteers

This study has finished and is no longer accepting participants.

In Australia
AddictionMedication studyAges 18–55
Countries
Australia
Sponsor
Definium Therapeutics US, Inc.
Drug study icon
CompletedNCT06524830

VLS-01 Buccal Film, Compared to Placebo for treatment-resistant depression

Official study title

A Phase 2, Multicenter, Double-blind, Randomized, Placebo-controlled Trial to Assess the Efficacy, Safety, and Tolerability of Repeated Doses of VLS-01 Buccal Film in Participants With Treatment Resistant Depression

This study has finished and is no longer accepting participants.

In Australia
DepressionMedication studyAges 18–65
Countries
Australia, United States, Canada, + 1 other
Sponsor
atai Therapeutics, Inc.
Drug study icon
CompletedACTRN12621000160831

Safety study of GRX-917 in Anxiety

Official study title

A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Ascending Doses of GRX-917 in Healthy Adult Subjects

This study has finished and is no longer accepting participants.

In Australia
AnxietyInterventional studyAges 18–55
Countries
Australia
Sponsor
Gaba Therapeutics Australia Pty Ltd a subsidiary of Gaba Therapeutics, Inc
Behavioral study icon
TerminatedACTRN12617000497303

Viability and efficacy of integrating the BeyondNow Suicide prevention smartphone app into a telephone support service for Suicide prevention

Official study title

A study to evaluate the viability and efficacy of integrating the BeyondNow suicide prevention smartphone app into a telephone support service for callers who are experiencing suicidal thoughts.

This study ended early.

Remote / online
SuicidalityInterventional studyAges 18+
Countries
Australia
Sponsor
Monash University

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.